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Introduction
Zinc (Zn) is an essential dietary micronutrient that
plays fundamental integrative roles in human physiol-
ogy. The functions of Zn can be divided into three cat-
egories: structural, catalytic, and regulatory. It is esti-
mated that 3-10% of human genes code for proteins
with Zn binding domains [1]. Since Zn cannot pas-
sively diffuse across cell membranes its transport is
carried out by Zn transporters. Two major unrelated
families of mammalian Zn transporters have been
identified: solute-linked carriers 30A (SLC30A, also
called ZnTs) and SLC39A (ZIPs) [2]. Zinc uptake is
mediated by the SLC39A protein family, while mem-
bers of the SLC30A family transport zinc from the
cytoplasm to the lumen of organelles or the extracellu-
lar space [3]. There is no storage form of Zn in the
body that can be readily mobilized when dietary intake
is inadequate. However, it has been shown that Zn
transporter expression can be regulated by both tran-
scriptional and post-transcriptional mechanisms in
response to Zn availability to ensure an appropriate
plasma concentration of this nutrient [3]. Zn trans-
porters have been strongly implicated in embryonic,
fetal, and neonatal development [2-5]. SLC30A1 and
SLC30A5 play a key role in regulating delivery of
maternal Zn to the developing embryo [2,5]. Cadmi-
um exposure, which is known to be risk factor for
congenital anomalies, down-regulates Slc30a1
expression, indicating that maternal cadmium expo-
sure may alter Zn homeostasis in the conceptus [5].
Mutations in ZnTs and ZIPs reveal their physiological
functions [3]. Mutations in SLC30A4 have been asso-
ciated with a loss or reduction of Zn secretory activi-
ty of some glandural epithelial cells, however the
regulation of Zn transporter proteins in histiotrophic
nutrition in early pregnancy has yet to be elucidated
[3,6,7]. Mutations in human SLC39A4 cause the rare
disease acrodermatitis enteropathica [8]. Interesting-
ly, it was been found that in the mouse, maternal
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e-mail: khozyasz@verco.com.plSlc39a4 haploinsufficiency results in increased sensi-
tivity to the effects of Zn deficiency and the risk of
abnormal embryonic development [8]. Recently,
Kambe et al. [9] demonstrated that the Slc39a1, 2,
and  3 genes evolved to decrease sensitivity to the
stress of dietary Zn deficiency in the reproducing
mouse. The high degree of evolutionary conservation
of ZIP1, 2, and 3 suggests the possibility of these
genes' involvement in protection against Zn deficien-
cy in human pregnancies [9].
Cleft lip with or without cleft palate (CL/P) is one
of the most common congenital malformations in
humans. The aetiology of CL/P is highly complex
and associated with both genetic and multiple envi-
ronmental factors, including micronutrient deficien-
cies [10]. The correlation between abnormal palato-
genesis and Zn dyshomeostasis has been clearly doc-
umented in laboratory animals [11]. In humans, poor
maternal Zn status may be a risk factor for clefting
when the micronutrient deficiency reaches a certain
severity [12,13]. Observations in the rodent model
indicate that the Zn transporter genes can be silent
when dietary intake of Zn is normal in pregnancy, but
they might be involved in buffering the micronutrient
deficiency and the success of reproduction can be dra-
matically compromised [14,15]. Such findings have
prompted the search for cleft-associated variants of Zn
transporters. Therefore, the present study was designed
to test single nucleotide polymorphisms (SNPs) of the
SLC30A and SLC39A genes as risk factors of having a
child with CL/P in the Polish population. 
Materials and methods
Participants. The study was approved by the local ethics commit-
tee. Index patients with non-syndromic cleft lip with or without
cleft palate were chosen by clinicians using detailed diagnostic
information from medical records in the Department of Paediatrics
and Department of Paediatric Surgery at the Institute of Mother
and Child in Warsaw. Peripheral blood samples from 149 healthy
mothers of children with orofacial clefts were obtained. In addi-
tion, 100 healthy mothers of children without congenital anomalies
were used as controls (control mothers). All participating omnivo-
rous women, aged 18-45 years, were Caucasians of Polish origin
recruited from the same geographic region. Written and oral con-
sent was obtained from all subjects. 
Genotyping. DNA was isolated from peripheral blood lymphocytes
by salt extraction. All 13 analyzed polymorphic variants of SLC30A1,
619 SNPs of genes encoding Zn transporters and orofacial clefts
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Table 1. Conditions for the identification of investigated SNPs
aBased on UCSC Human Genome Browser, February 2009 (GRCh37) assembly; bAccording to the Single Nucleotide Polymorphism database (dbSNP); 
cUppercase denotes the more frequent allele in the control samples.620 K. Hozyasz et al.
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Table 2. Genotype frequencies of the investigated polymorphisms in mothers of children with CL/P and control mothers
aChi-square analysis; bFisher exact test; MAF, minor allele frequency.621 SNPs of genes encoding Zn transporters and orofacial clefts
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2010:48(4): 621 (618-623) 
Doi: 10.2478/v10042-010-0055-6
SLC30A4, SLC30A5, SLC39A1, and SLC39A3 were identified using
PCR followed by appropriate restriction enzyme digestion (PCR-
RFLP). DNA fragments were separated using electrophoresis on 2%
agarose gel and visualized using ethidium bromide staining. Primer
sequences and conditions for PCR-RFLP analyses are presented in
Table 1. The selection of SNPs was conducted through the use of the
genome browser of the International HapMap Consortium
(www.hapmap.org). SNPs were prioritized according to their valida-
tion status, functional relevance and importance, and minor allele fre-
quency MAF>0.1 in the Caucasian population.
Statistical analysis. The differences in allele and genotype fre-
quencies between case mothers and controls were determined
using standard χ2 and Fisher exact tests. The odds ratio (OR) and
associated 95% confidence intervals (95% CI) for mothers of chil-
dren with CL/P versus control mothers were also calculated.
Haplotype analysis was performed using Haploview 4.0
(http://www.broadinstitute.org/mpg/haploview). Associations
between the investigated polymorphisms and the risk of having a
child with an orofacial cleft were tested using the nonparametric
and genetic model-free Multifactor Dimensionality Reduction
(MDR) approach (MDR version 2.0 beta 5). Statistical significance
was evaluated using a 1,000-fold permutation test (MDR permuta-
tion testing module 0.4.9 alpha). A p-value of <0.05 was consid-
ered statistically significant.
Results
For all analysed polymorphisms of the SLC30A1,
SLC30A4, SLC30A5, SLC39A1, and SLC39A3 genes
there was no evidence for both allelic and genotyping
association with the risk of being a case mother in the
Polish population. The genotyping results are present-
ed in Table 2. No deviation from Hardy-Weinberg
equilibrium in either CL/P mothers or control mothers
at the 0.05 level was observed. The minor allele fre-
quency for all SNPs was at least 0.19. Haplotype
analysis did not detect differences in haplotype distri-
bution between case and control mothers (Table 3).
Moreover, the exhaustive MDR analysis revealed no
significant interactive genetic effect on having a child
with CL/P for all analysed SNPs (Table 4). All possi-
ble two-, three- and four-way SNP interactions were
tested using 10-fold cross validation in an exhaustive
search (considering all possible SNP combinations).
All of the "best models" (showing highest testing bal-
anced accuracy and cross validation consistency >5
out of 10) did not reach the statistical significance
evaluated using a 1,000-fold permutation test.
Discussion
Genetic studies in humans have shown associations
between expression profiles of genes for Zn transporters
and chronic diseases (diabetes, asthma) as well as car-
cinogenesis [16,17]. Since craniofacial malformations
arise from misregulation of normally coordinated tissue
patterns during early embryogenesis [10], another inter-
esting aspect of Zn transporter function is the possibili-
ty of these proteins' involvement in early embryonic
nutrition. It has been demonstrated that the expression
of the Slc30a1 gene is highly active in the yolk sac of
the developing mouse embryo, and this expression is
partially dependent on maternal Zn intake [18]. Due to
the key role of Zn in human physiology, the aim of this
study was to verify possible contributions of Zn trans-
porter gene SNPs to orofacial clefting. To our knowl-
edge, the present report is the second association study
examining the potential role of genes encoding Zn trans-
porters in the aetiology of non-syndromic structural
malformations in affected progeny. In a sample of
Dutch triads of patients and their parents, no association
was observed between the 1069C>T (rs2272662) vari-
ant of SLC39A4 and spina bifida [19]. In our study the
investigated SNPs were not found to be associated with
the women's risk of having children with CL/P, analyzed
either separately or in combination. We analyzed three
polymorphisms of the gene for the SLC30A1 protein,
which plays an essential function in transporting mater-
nal Zn into the embryo, and two polymorphic variants
of the gene for SLC39A1 protein, which has been
detected in a wide variety of tissues and cell types [3]. 
Table 3. Haplotypes and their association with maternal risk of
having CL/P progeny622 K. Hozyasz et al.
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It has been shown that mRNA levels of both
SLC30A1 and SLC39A1 may be potential Zn status
indicators in the human lymphoblastoid cell line [20].
In women of childbearing age supplemented with Zn,
the expression of SLC39A1 in leucocytes has been
reported to decrease significantly, whereas there were
no changes in the mRNA levels of SLC30A1 [20].
Therefore, SLC39A1 mRNA expression is considered
a potential biomarker of Zn status in humans. In con-
trast to these predictions, the allele and genotype dis-
tribution of SLC30A1 and SLC39A1 polymorphic vari-
ants was found to be similar among the investigated
mothers of CL/P affected children and controls. 
In the present study, the allele distribution of
SLC30A5 rs351444 showed the highest difference
between case and control mothers. Moreover, the risk of
having a CL/P affected child for the maternal rs351444
GG genotype compared with the wild type tended to be
decreased (OR=0.55; 95%CI: 0.26-1.16; p=0.11). Inter-
estingly, haplotype analysis of SLC30A5 polymorphic
variants (rs351444, rs164393, and rs6886492) showed
borderline association between the CTA haplotype and
increased risk of clefting (p=0.051).
Expression of SLC30A4 appears to be independent
of Zn status, which is contrary to SLC30A1, SLC30A5,
SLC39A1, and SLC39A3 [21]. It is noteworthy that
there was no evidence for association of polymorphic
variants of SLC30A4 with CL/P risk. The analysis of
epistasis is helpful in determining the true contribution
of genetic factors to congenital anomaly susceptibility
[22]. However, in our study the exhaustive MDR
analysis revealed no significant interactive effect of
polymorphic variants of the genes for Zn transporters
on abnormal palatogenesis. There are no previously
published clinical association studies of the SNPs ana-
lyzed in the present report, and so we are unable to
compare our results with data from other studies.
However, our negative results do not exclude the
potential role of polymorphisms of Zn transporter
genes in the aetiology of CL/P. The results might be
influenced by the sample size, which may not be large
enough to detect a modest effect of the analyzed gene
variants. We cannot exclude that SNPs in genes for Zn
transporters may influence palatogenesis via the
embryonic, rather than the maternal, genotype. In
humans, some of genes for Zn transporters may have a
restricted expression to only fetal tissues [23]. There-
fore, the exclusion of the investigated SNPs and other
variants of genes encoding Zn transporters as risk fac-
tors of CL/P in the Polish population requires further
analyses, which should be performed in larger groups
of case and control mothers as well as in CL/P-affect-
ed children. The relatively high and fluctuating fre-
quency of orofacial clefts is attributable to the sensi-
tivity of facial development to environmental insult.
Recent progress in our understanding of the molecular
functions of Zn transporters and their clinical associa-
tions has revealed that additional analysis involving
polymorphisms of SLC30A8 and  SLC39A14 may
throw a new light on the aetiology of CL/P. Maternal
diabetes and infection with the common cold during
early pregnancy are well known risk factors for abnor-
mal palatogenesis [10,24]. SLC39a14 plays a major
role in hypozincemia induced by inflammation, which
is among the classical changes observed during acute
infections [3]. In rodents, dietary Zn supplementation
decreases the frequency of malformations caused by
bacterial lipopolysaccharides [25]. The association
between some polymorphisms of SLC30A8 and the
onset of diabetes mellitus is well documented in
humans [3].
In summary, the presented results did not support
any association between maternal polymorphisms of
SLC30A and SLC39A genes and the risk of having an
infant with CL/P in the investigated Polish population.
However, given the high heterogeneity of the associa-
tion between the maternal Zn blood level and the risk
of clefting [13], we suspect that genes acting in Zn
homeostasis could be involved in CL/P onset and
deserve further investigation. 
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Table 4. Results of gene-gene interactions analyzed by MDR method
aTesting balanced accuracy is the accuracy of classification of cases and controls in the testing dataset calculated as (Sensitivity+Specificity)/2; 
bCross validation consistency is the number of times the model was selected as the best model after 10-fold cross-validation runs; 
cSignificance of accuracy (empirical p value based on 1,000 permutations).623 SNPs of genes encoding Zn transporters and orofacial clefts
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